This year's Medical Innovation Summit will highlight neurosciences innovation
Thousands of researchers, investors, entrepreneurs and those who are simply curious will descend upon the Cleveland Convocation Center October 26-28 for Cleveland Clinic Innovations Medical Innovation Summit. This year’s theme, The Neurosciences: Memory. Mood. Movement, will cover all aspects of the human brain and how it functions and malfunctions.
Cleveland Clinic Innovations to partner with Israeli health care companies
Cleveland Clinic’s business development arm announced it will lend its commercialization services to Israeli health care companies looking to do business in the United States.
In-Depth: Digital health news recap of H1 2015
The first six months of 2015 have been chock-full of digital health news. What follows is an exhaustive recap of the first half of the year with links to MobiHealthNews coverage of notable events throughout. If you’d prefer to navigate to a particular section, here’s where you can find our digital health news round-up section for payor news, pharma news, government and regulatory news, mergers and acquisitions, funding announcements, and survey results, market data, and other industry metrics. Or read on below for our round-up of healthcare provider-focused digital health news.
Cleveland Clinic launches urgent care video visits app for Ohio Residents
Cleveland Clinic has released a new video visits app for Ohio residents, called MyCare Online, that offers patients 24-hour access to a medical professional for urgent care needs. The service is powered by American Well.
New Ventures in Healthcare Challenge to kick off Medical Innovation Summit
Cleveland Clinic Innovations Medical Innovation Summit is set to take place from October 25th-28th this year. It will once again kick off with the New Ventures Healthcare Challenge, the search for the next great early-stage health IT company poised to hit the market with better healthcare solutions.
ContraVir Pharmaceuticals Selects ImageIQ as Imaging CRO for Phase III Clinical Trial
ImageIQ an innovative Imaging Software and Contract Research Organization for preclinical research and clinical trials announced today that it has been chosen by ContraVir Pharmaceuticals Inc. a biopharmaceutical company focused on the discovery and development of targeted antiviral therapies to provide its full complement of clinical research imaging support services and technology for ContraVir’s Phase III clinical trial of FV-100 an orally available nucleoside analogue prodrug for the treatment of shingles an infection caused by the reactivation of varicella zoster virus (VZV) and shingles-associated pain known as post-herpetic neuralgia (PHN). Specifically ContraVir will leverage ImageIQ’s EDCIQ™ imaging-enabled electronic data capture (EDC) system customized specifically to the study’s design and workflow to support the management and compliance of all imaging-related activities. ImageIQ will deploy manage and support mobile imaging devices for field personnel who will capture images of the zoster rash for each study participant across multiple time points. Once acquired images and data will be automatically uploaded to the EDCIQ by a mobile application for immediate centralized QA and reporting followed by Dermatologist image evaluation using an EDCIQ integrated image viewer and measurements tools. Lastly ImageIQ will develop and validate the imaging and image evaluation protocols as well as provide image acquisition qualification training and imaging-related management for all study sites and field personnel participating in the study. ImageIQ is a Cleveland Clinic Innovations company.
Illingworth Research Selects ImageIQ’s EDC IQ to Support Imaging Workflow and Compliance in Dermatology Global Phase I-IV Clinical Trials
CLEVELAND--(BUSINESS WIRE)--ImageIQ, an innovative Imaging Software and Contract Research Organization for preclinical research and clinical trials, announced that Illingworth Research Ltd., a leading European clinical research organization (CRO) based near Manchester, UK, has selected ImageIQ’s imaging-enabled electronic data capture technology, EDCIQ. With the EDCIQ technology, they will streamline, manage and enable the imaging workflows of the global dermatology clinical trials that Illingworth Research supports with operational and medical photography expertise. The EDCIQ will enable Illingworth to centralize and monitor all imaging-related activities, as well as further ensure full compliance with study design and imaging protocols for all of its clinical research sponsors, study sites and partners.